Keep up with our core and affiliated faculty in the national and international news. Read their op-ed pieces, quotes and interviews, and cutting-edge research findings.
SciPol lead editor and senior research scientists with Duke Robotics, Dr. Michael Clamann, weighs in on Tesla’s reveal of their new electric semi-truck. How will this technology change the truck driving industry and are there regulatory and security concerns that need to be addressed?
When it comes to managing anxiety, science just lent more credibility to the advice to “stay busy.” Engaging the brain to stay busy with problem-solving appears to be an effective buffer against debilitating anxiety, especially in those prone to the worst of the condition, according to a new brain imaging study from Duke University researchers.
Read the full article on Forbes.com
In order to succeed, you need to be able to tell a good story.
Five years after sharing the 2012 Nobel Prize in Chemistry with his former student, Stanford’s Brian Kobilka, Robert Lefkowitz of the Duke University Medical Center continues lab work. At age 75, he’s still building on the groundbreaking discoveries that reveal the functions of G protein-coupled receptors which drive the effects of half of all medications. He also contemplates issues as timeless and conventional as the importance of mentors and as topical and controversial as the danger of the anti-science attitudes of the current presidential administration. At the fifth anniversary of his becoming a Nobel laureate, Lefkowitz sat with Emilia Chiscop-Head, an internationally awarded journalist now working at Duke University Initiative for Science & Society, for a wide-ranging discussion.
Read the full interview on Duke Today.
Scientists at Duke University have identified a neuron that acts as the “master controller” of habits. The findings, published in the journal eLife, could someday change the ways addiction and compulsive behavior are treated.
Nothing goes together like professional football and genetic testing, amiright?
That’s what the Baltimore Ravens and Orig3n, a Boston direct-to-consumer genetic testing company, apparently thought when they came up with the idea for “DNA Day” at the team’s M&T Bank Stadium.
The plan was to provide free genetic test kits, emblazoned with the Ravens logo, to fans at this past Sunday’s game against the Cleveland Browns. Interested folks could swab some cells off the inside of their cheek and hand them off at the stadium. Orig3n (and no, that is not a typo) would then analyze four genes in those cells. Easy peasy.
But shoot, DNA Day was postponed at the last minute. The Baltimore Sun reported Monday that both federal and state agencies had raised questions about the promotion.